Shares of McKesson Co. (NYSE:MCK) have earned a consensus rating of “Hold” from the twenty-one ratings firms that are presently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and eleven have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $173.92.
Several research analysts have commented on MCK shares. Robert W. Baird raised shares of McKesson from a “neutral” rating to an “outperform” rating and lifted their price objective for the stock from $175.00 to $178.00 in a research note on Tuesday, September 19th. Mizuho set a $168.00 price objective on shares of McKesson and gave the stock a “hold” rating in a research note on Tuesday, October 24th. ValuEngine raised shares of McKesson from a “hold” rating to a “buy” rating in a research note on Tuesday, October 31st. Credit Suisse Group reaffirmed an “underperform” rating and set a $130.00 price objective (down from $155.00) on shares of McKesson in a research note on Thursday, November 9th. Finally, Zacks Investment Research raised shares of McKesson from a “hold” rating to a “buy” rating and set a $177.00 price objective for the company in a research note on Tuesday, December 26th.
McKesson (NYSE:MCK) traded down $1.78 during midday trading on Tuesday, reaching $155.95. 641,663 shares of the company’s stock traded hands, compared to its average volume of 1,940,000. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.05 and a quick ratio of 0.61. The stock has a market capitalization of $32,880.00, a price-to-earnings ratio of 7.39, a price-to-earnings-growth ratio of 1.60 and a beta of 1.23. McKesson has a 52 week low of $133.82 and a 52 week high of $169.29.
McKesson (NYSE:MCK) last posted its quarterly earnings data on Thursday, October 26th. The company reported $3.28 EPS for the quarter, topping the consensus estimate of $2.78 by $0.50. The company had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.69 billion. McKesson had a net margin of 2.24% and a return on equity of 24.87%. McKesson’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.94 earnings per share. research analysts anticipate that McKesson will post 12.19 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 2nd. Stockholders of record on Friday, December 1st will be given a dividend of $0.34 per share. The ex-dividend date is Thursday, November 30th. This represents a $1.36 annualized dividend and a dividend yield of 0.87%. McKesson’s dividend payout ratio (DPR) is 6.44%.
In related news, Chairman John H. Hammergren sold 65,000 shares of McKesson stock in a transaction dated Thursday, December 14th. The stock was sold at an average price of $160.00, for a total value of $10,400,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.20% of the stock is currently owned by company insiders.
Several hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. raised its holdings in shares of McKesson by 8.0% in the second quarter. BlackRock Inc. now owns 15,330,001 shares of the company’s stock valued at $2,522,396,000 after acquiring an additional 1,131,024 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of McKesson by 0.4% in the second quarter. Vanguard Group Inc. now owns 14,090,544 shares of the company’s stock valued at $2,318,457,000 after acquiring an additional 62,004 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in shares of McKesson by 6.5% in the third quarter. Bank of New York Mellon Corp now owns 2,540,305 shares of the company’s stock valued at $390,217,000 after acquiring an additional 154,967 shares in the last quarter. Pzena Investment Management LLC raised its holdings in shares of McKesson by 17.2% in the third quarter. Pzena Investment Management LLC now owns 2,458,531 shares of the company’s stock valued at $377,655,000 after acquiring an additional 360,676 shares in the last quarter. Finally, Wells Fargo & Company MN raised its holdings in shares of McKesson by 12.7% in the second quarter. Wells Fargo & Company MN now owns 2,121,171 shares of the company’s stock valued at $349,017,000 after acquiring an additional 239,358 shares in the last quarter. Hedge funds and other institutional investors own 87.88% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “McKesson Co. (MCK) Receives Consensus Recommendation of “Hold” from Analysts” was first posted by Transcript Daily and is the property of of Transcript Daily. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://transcriptdaily.com/2018/01/01/mckesson-co-mck-receives-consensus-recommendation-of-hold-from-analysts.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.